K2LTS Telomerase Inhibitor

Manufacturer
K2LT LAB, LLC
Effective date
2024-08-19
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 20:56:25

Label at a glance#

ProductK2LTS Telomerase Inhibitor
Active ingredientGINSENOSIDES
Label structure13 sections

Dosage and administration

Usage: Twist off the bottle cap and take it directly; Take it twice a day; Do not overdose.

Storage and handling

Storage: This product should be stored in a cool, dry, dark place with the temperature of 16℃-27℃ and the humidity ≤ 50%.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

ginsenoside 23%

Purpose

OTC - PURPOSE SECTION

Indications: This drug is indicated for cancer patients, people with a family history of cancer, or people exposed to work with radioactivity.

Use

INDICATIONS & USAGE SECTION

Product Benefits: This product can inhibit the activity of telomerase, thus preventing the proliferation and growth of tumor cells;

Warnings

WARNINGS SECTION

This product should not be used in combination with antibiotics;

Do not use

OTC - DO NOT USE SECTION

This product should not be used in patients who are allergic to any component of this product;

When Using

WARNINGS SECTION

Precautions: Combined use with other drugs or increased exposure to this product may result in clinically significant adverse reactions. Combined use with other drugs may significantly decrease the concentration of this product, leading to decreased therapeutic effect of the drug combination.

Stop Use

OTC - STOP USE SECTION

If there is any discomfort during use, please discontinue this product.

Ask Doctor

OTC - ASK DOCTOR SECTION

If the patient has any underlying medical condition, please consult the doctor before taking this product.

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Please keep this product away from children. If the child accidentally ingests this product, please seek medical help immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Usage: Twist off the bottle cap and take it directly; Take it twice a day; Do not overdose.

Other information

STORAGE AND HANDLING SECTION

Storage: This product should be stored in a cool, dry, dark place with the temperature of 16℃-27℃ and the humidity ≤ 50%.

Inactive ingredients

INACTIVE INGREDIENT SECTION

EGCG Sulforaphane cordycepin Ergothioneine Selenium Sodium benzoate

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84429-002K2LTS TELOMERASE INHIBITOR (TELOMERASE INHIBITOR) LIQUID [K2LT LAB, LLC]2Unmatched20240820_1b4daf1d-a7a5-8fd1-e063-6294a90a817e.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84429-00284429-002-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
496a0200-4d3a-cde3-e063-6294a90a897f1b4daf1d-a7a5-8fd1-e063-6294a90a817e2026-01-27WarningsExact identifier
spl set id: 1b4daf1d-a7a5-8fd1-e063-6294a90a817e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.